Abstract |
Laparoscopic, ultrasound-guided radiofrequency ablation (RFA) is a new, FDA-cleared uterine sparing, outpatient procedure for uterine fibroids. The procedure utilizes recent technological advancements in instrumentation and imaging, allowing surgeons to treat numerous fibroids of varying size and location in a minimally invasive fashion. Early and mid-term data from multi-center clinical trials have demonstrated safety and efficacy, with resolution or improvement of symptoms and significant volume reduction. Re-intervention rates for fibroid symptoms have been low. The procedure is well tolerated with a typically uneventful and rapid recovery requiring NSAIDs only for postoperative pain. While post RFA pregnancy data are limited, the results are promising.
|
Authors | Bruce B Lee, Steve P Yu |
Journal | Current obstetrics and gynecology reports
(Curr Obstet Gynecol Rep)
Vol. 5
Issue 4
Pg. 318-324
( 2016)
ISSN: 2161-3303 [Print] United States |
PMID | 27917310
(Publication Type: Review, Journal Article)
|